Centre celebrates science communication award
28 November 2013
Maurice Wilkins Centre investigator Dr Siouxsie Wiles from the University of Auckland was honoured at the Royal Society of New Zealand’s awards ceremony last night.
Prestigious honour for two Centre investigators
21 November 2013
The Maurice Wilkins Centre is celebrating the election of two of its incoming principal investigators as Fellows of the Royal Society of New Zealand.
International award for New Zealand drug inventor
20 November 2013
Maurice Wilkins Centre principal investigator Distinguished Professor Bill Denny has been named the recipient of the American Chemical Society’s 2014 Medicinal Chemistry Award.
Strategic collaboration between New Zealand and Chinese scientists initiates quest for new cancer treatments
15 November 2013
The Maurice Wilkins Centre is delighted that researchers from the Centre are involved in both of the joint New Zealand-Chinese Strategic Research Alliance research projects in the non-communicable disease category announced last night.
Top science communicator celebrated
13 November 2013
Maurice Wilkins Centre associate investigator Dr Siouxsie Wiles, from the University of Auckland, was last night awarded the 2013 Prime Minister’s Science Media Communication Prize.
Hands-on scientific research for school students
14 October 2013
The Maurice Wilkins Centre is delighted to have helped secondary school students from around the upper North Island attend a unique hands-on science day recently. The Centre provided sponsorship for groups of students to travel from Kawerau, Rotorua and Whitianga to the Univ...
Twenty-three more scientists join our network
4 October 2013
The Maurice Wilkins Centre brings together top researchers from around the country and across a range of disciplines, and our network continues to grow.
New chemistry transforms vaccine manufacture
2 October 2013
Honours student Tom Wright, from The University of Auckland, has created a new kind of chemistry to dramatically simplify the manufacture of drugs targeting the immune system, and the technology has been patented.